Xaira Therapeutics

Acquisition, funding and merger involving Xaira Therapeutics.

• Xaira Therapeutics becomes a unicorn with its fundraising of $1,000 Million. (posted on April 25 2024).

View the org chart displaying its 11 main executives

Most searched biographies at Xaira Therapeutics

• Marc Tessier-Lavign, Chief Executive Officer and Director
• Bryan White, Director
• Kaye Foste, Director

Popular executive movements at Xaira Therapeutics

• Carolyn Bertozzi has joined the company as Director  (posted on April 25 2024).
• Kaye Foste has joined the company as Director  (posted on April 25 2024).
• Vikram Bajaj has joined the company as Director  (posted on April 25 2024).

Create your alert
to follow the executive moves at Xaira Therapeutics.

Xaira Therapeutics has 1,829 competitors including IQVIA (United States (USA)), Siemens Healthineers (Germany) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• SmarterDx has just announced a $50 Million fundraising (posted on May 16 2024).
• KKR has announced the acquisition of Healthium  (posted on May 9 2024).
• Rad AI has just announced a $50 Million fundraising (posted on May 7 2024).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Paulo Junqueira Moll - Chief Executive Officer at Rede D'Or Sao Luiz
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care

Learn more about the Healthcare industry >

Press releases by Xaira Therapeutics

Social media about Xaira Therapeutics

• Xaira Therapeutics on Wikipedia, Google News & Yahoo Finance
• Xaira Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Carolyn Bertozzi

Call Xaira Therapeutics at +1 773...

View the org chart

Register to receive your alert

Report an error